Clinical Trial Update: Neurofeedback in Clinical High Risk [NA]

View source ↗

Summary

A clinical trial update for a neurofeedback study in individuals at clinical high risk for psychosis, comparing real DMN neurofeedback to sham motor cortex neur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psychosis
• Schizophrenia

Snippet

Sponsor: Boston VA Research Institute, Inc. | Conditions: Real Neurofeedback From DMN, Sham Neurofeedback From Motor Cortex | NA | Status: NOT_YET_RECRUITING